CANCER GENETICS, INC Note Agreements
12 Contracts & Agreements
- Exhibit 10.1 Note Purchase Agreement with Atlas Sciences (Filed With SEC on October 25, 2019)
- Exhibit 4.1 Promissory Note with Atlas Sciences (Filed With SEC on October 25, 2019)
- Promissory Note of Interpace BioPharma, Inc., dated July 15, 2019, in favor of Cancer Genetics, Inc (Filed With SEC on July 19, 2019)
- Promissory Note, dated September 18, 2018, in favor of NovellusDx Ltd (Filed With SEC on September 21, 2018)
- Convertible Promissory Note (Filed With SEC on July 18, 2018)
- PROMISSORY NOTE (Filed With SEC on December 14, 2012)
- RESTATED PROMISSORY NOTE (Filed With SEC on October 23, 2012)
- PROMISSORY NOTE (Filed With SEC on March 13, 2012)
- PROMISSORY NOTE (Filed With SEC on March 13, 2012)
- PROMISSORY NOTE (Filed With SEC on December 30, 2011)
- CANCER GENETICS, INC. CONVERTIBLE PROMISSORY NOTE 1 (Note) (Filed With SEC on December 30, 2011)
- CANCER GENETICS, INC. CONVERTIBLE PROMISSORY NOTE 1 (Note) (Filed With SEC on December 30, 2011)
